The Junera™ Blog
Clinical insights, technology deep-dives, market intelligence, and patient education from the Onyxa Medical™ team.
Founders Circle Event Colorado: A Hands-On Training Recap
September 24, 2026. Onyxa Medical. 3 min read. community. founders circle. event. training. Seven physicians who attended the Founders Circle Event in Broomfield, Colorado describe Junera training, peer collaboration, and support in their own words.
What to Expect: Recovery and Results After Subdermal Laser Treatment
February 10, 2026. Onyxa Medical. 6 min read. patient education. recovery. results. aftercare. One of the most common questions patients ask is about recovery time and when they'll see results. This guide walks through the typical healing timeline, aftercare best practices, and what to expect as collagen remodeling progresses.
Understanding Dual-Wavelength Laser Technology: 980nm and 1470nm
February 5, 2026. Onyxa Medical. 7 min read. technology. education. wavelengths. Dual-wavelength laser platforms combine two complementary wavelengths to address multiple tissue targets simultaneously. This article explains the science behind 980nm and 1470nm wavelengths and how they work together for tissue remodeling.
The GLP-1 Opportunity: Why Tissue Remodeling Demand Is Surging
January 28, 2026. Onyxa Medical. 5 min read. market trends. glp 1. body contouring. With millions of patients achieving significant weight loss through GLP-1 medications, the demand for skin tightening and body contouring solutions is growing rapidly. Here's what aesthetic physicians need to know about this emerging market.
Subdermal Laser vs. RF Microneedling: Understanding the Key Differences
January 15, 2026. Onyxa Medical. 8 min read. technology. education. skin tightening. comparison. Patients exploring non-surgical skin tightening have more options than ever. This article compares subdermal laser tissue remodeling with radiofrequency microneedling — examining mechanism of action, clinical evidence, recovery, and expected outcomes.
Introducing the AES: Objective, AI-Computed Outcome Measurement for Aesthetic Medicine
April 21, 2026. Onyxa Medical. 6 min read. clinical evidence. practice growth. technology. education. Onyxa Medical's Clinical Research Group has published validation data for the Weighted AES — a three-source, 10-point outcome metric that blends AI pillar analysis (70%), blinded physician GAIS (25–30%), and patient self-assessment (5%). In a 22-case retrospective analysis, the Weighted AES demonstrated a mean score of 6.4 with 21.3% composite improvement across four morphological pillars.